跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Dialiptin
Approved
STANDARD
Dialiptin
J.M. Tolmann Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
777964d9ff3ba284
Company
J.M. Tolmann Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
777964d9ff3ba284
Drug Approval Philippines Name
Dialiptin
Product Name
Dialiptin
Registration Number
DRP-11314
Brand Name
Dialiptin
Generic Name
Sitagliptin (as Phosphate)
Dosage Form
Film-Coated Tablet
Dosage Strength
25 mg
Manufacturer
J.M. Tolmann Laboratories, Inc.
Issuance Date
24 February 2022
Expiry Date
24 February 2027
Pharmacologic Category
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
777964d9ff3ba284
Type
Standard
Back to Philippines FDA Approvals
Dialiptin - Philippines FDA Drug Approval Details